Amber Myers is a PharmD with a background in compounding and an emphasis in functional medicine. She has presented at the LDN (Low Dose Naltrexone) conference for use in the eye, as well as local LDN presentations. She has also assisted in the research of terpenes and validating clinical guidelines for an essential oils book. In her free time, Amber has spent time learning the application of herbal therapies and making herbal preparations. Amber excels in her ability to identify legitimate scientific data and teach the whole range of audience, from practitioner to patient.
As Director of Clinical Development, Amber’s role at Encore Life is to support practitioners in their practice and provide current research and data on CBD. Amber is also actively involved in the R&D process to help develop innovative new products and dosage forms.